Displaying 25 - 36 of 40
Viral Hepatitis
6

Gilead Sciences: A new beginning in hepatitis delta - ILC 2021

View
Viral Hepatitis
6

Gilead Sciences: A new beginning in hepatitis delta - ILC 2021

View
Viral Hepatitis
5

Gilead Sciences: The Next Chapter in Viral Hepatitis - ILC 2021

View
Viral Hepatitis
5

Gilead Sciences: The Next Chapter in Viral Hepatitis - ILC 2021

View
Viral Hepatitis
5

Gilead Sciences: The Next Chapter in Viral Hepatitis - ILC 2021

View
Viral Hepatitis
5

Gilead Sciences: The Next Chapter in Viral Hepatitis - ILC 2021

View
Viral Hepatitis
5

Gilead Sciences: The Next Chapter in Viral Hepatitis - ILC 2021

View
Viral Hepatitis
4

AbbVie: How Can We Accelerate HCV Elimination in the Current Landscape? - Digital ILC 2020

View
Viral Hepatitis
4

AbbVie: How Can We Accelerate HCV Elimination in the Current Landscape? - Digital ILC 2020

View
Viral Hepatitis
4

AbbVie: How Can We Accelerate HCV Elimination in the Current Landscape? - Digital ILC 2020

View
Viral Hepatitis
4

AbbVie: How Can We Accelerate HCV Elimination in the Current Landscape? - Digital ILC 2020

View
Viral Hepatitis
5

Gilead: A NEW VIRUS IN THE MIX: Re-imagining liver disease care in the COVID-19 era - Digital ILC 2020

View
Displaying 25 - 36 of 40